NVAX Technical Analysis
NVAX has been showing some solid bullishness since settling the Gavi dispute. NVAX is pumping out of the buy zone, and there has been a bullish breakout above the light blue resistance line. The key price target ahead is the green resistance line ($6.36), a yellow resistance zone ($8.20 to $8.46), and a red resistance line ($10.23). I have...
NVAX has started distributing millions of COVID-19 vaccine shots. However, NVAX is trending back down towards the buy zone. I think that this will present a great second chance buy opportunity after NVAX's recent rally to $8. The markets have been affected by the new Israel Palestine conflict. Other key events this week are September PPI inflation data and Fed...
NVAX as seen on the weekly chart has been in price distress for a long time.
It has only one product on the market due to various issues with the FDA process.
It has a variety of products in development as linked below.
The question is whether it will run out of cash before a sustained revenue
stream develops. FDA approvals for the pipeline products could take...
Hi guys, NVAX showed up on my feed today as down 25% so I decided to take a look. What I see is a text book Bearish Shark attack on the stock. Looking at the embedded image in this chart you can compare the events as they occurred. The stock price has also gone back to beginning of the rally.
Please do your DD this is not a financial advice.
Novavax - 30d expiry - We look to Sell a break of 15.49 (stop at 17.01)
Daily signals are bearish.
There is no clear indication that the downward move is coming to an end.
Prices are extending lower from the bearish flag/pennant formation.
Posted a bearish Flag formation.
A break of 15.50 is needed to confirm the outlook.
The bias is to break to the...
